4 recruiting, 3 terminated, 2 active not recruiting, 2 completed. 13 Phase 2, 4 Phase 1, 2 Phase 3.
Follow Dysbiosis: new trials by email Literature Review of Dysbiosis trials Research Report on Dysbiosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Herbal Supplement (Biocidin REMOVE) for Bacterial Overgrowth in Irritable Bowel Syndrome Biocidin REMOVE, Placebo - Irritable Bowel Syndrome (IBS), Small Intestinal Bacterial Overgrowth Syndrome (SIBO) | Phase 2 | Recruiting | Johns Hopkins University | 40 | 2026-10-26 | 2026-11-16 |
| Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma EXL01 - Hepatocellular Carcinoma | Phase 2 | Recruiting | Center Eugene Marquis | 34 | 2025-03-12 | 2025-08-05 |
| Fecal Microbiota Translantation (FMT) to Reduce Inflammation in PLWH: The Gutsy Pilot Study FMT capsules, Placebo capsules - HIV-1-infection | Phase 2 | Completed | Jean-Pierre Routy | 20 | 2024-07-31 | 2025-09-03 |
| INVESTIGATION of the EFFICACY and SAFETY of the DRUG "AS-PROBIONORM" "AS-Probionorm" - Intestinal Infections, Dysbacteriosis | Phase 2 | Completed | Industrial Microbiology LLP | 210 | 2024-07-22 | 2025-03-20 |
| Microbiome Alterations With Xylitol (MAX) in Pregnancy Xylitol gum, Sorbitol gum - Dysbiosis, Inflammation Gum | Phase 1 / Phase 2 | Active not recruiting | Baylor College of Medicine | 80 | 2024-06-13 | 2026-03-10 |
| Fecal Microbiota Transplantation in Axial Spondyloarthritis FMT, Placebo - Axial Spondyloarthritis, Ankylosing Spondylitis | Phase 2 | Recruiting | University Hospital of North Norway | 99 | 2024-06-01 | 2026-08-14 |
| Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT Probiotic, Placebo - Microtia, Dysbiosis | Phase 2 | Recruiting | Vanderbilt University Medical Center | 250 | 2023-09-18 | 2026-08-27 |
| Oral Iron Supplementation for Patients With Chronic Kidney Disease Ferrous sulfate 3 days week, Ferrous sulfate daily, Ferrous sulfate higher concentration - Chronic Renal Disease, Iron-Deficiency Anemia | Phase 2 | Active not recruiting | Universidade Federal Fluminense | 6 | 2022-08-01 | 2025-04-03 |
| Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children Pancreatic Enzyme, Ursodeoxycholic acid, Pancreatic Enzyme placebo - SEPSIS, MALNUTRITION, CHILD | Phase 2 / Phase 3 | Unknown | University of Oxford | 400 | 2021-07-01 | 2023-02-24 |
| Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis Rosuvastatin 10mg - Ulcerative Colitis | Phase 2 / Phase 3 | Terminated | Universitaire Ziekenhuizen KU Leuven | 177 | 2020-10-22 | 2025-11-25 |
| Fecal Microbiota Transplant for Primary CDI Fecal microbiota transplant G3 capsules, Oral Vancomycin alone - Clostridium Difficile Infection | Phase 1 / Phase 2 | Terminated | Boston Medical Center | 5 | 2019-08-23 | 2021-12-15 |
| Safety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD) Fecal Microbiota Transplantation (FMT), Saline - Clostridial Infection, Dysbiosis | Phase 1 / Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 10 | 2019-01-11 | 2022-05-02 |
| SHIFT: Studying HIV Immunology After Fecal Transplant Fecal Inoculum Capsule, Placebo (for Fecal Inoculum Capsule), Antibiotic - HIV/AIDS, Dysbiosis | Phase 1 / Phase 2 | Withdrawn | Massachusetts General Hospital | 2018-06-01 | 2018-11-15 |
Inflammation (3) · Clostridium Infections (2) · Acquired Immunodeficiency Syndrome (1) · Alcohol Drinking (1) · Anemia, Iron-Deficiency (1) · Arthritis (1) · Axial Spondyloarthritis (1) · Carcinoma, Hepatocellular (1) · Cardiovascular Diseases (1) · Child Nutrition Disorders (1) · Colitis, Ulcerative (1) · Congenital Microtia (1) · Gingivitis (1) · HIV Infections (1)
Pathologic Processes (13) · Pathological Conditions, Signs and Symptoms (13) · Infections (7) · Digestive System Diseases (3) · Urogenital Diseases (3) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Blood-Borne Infections (2) · Colonic Diseases (2) · Communicable Diseases (2) · Gastrointestinal Diseases (2) · Genital Diseases (2) · Gram-Positive Bacterial Infections (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2)
Fecal Microbiota Transplantation (2) · Anti-Bacterial Agents (1) · Pancrelipase (1) · Probiotics (1) · Rosuvastatin Calcium (1) · Sodium Chloride (1) · Ursodeoxycholic Acid (1) · Vancomycin (1) · ferrous sulfate (1)
Baylor College of Medicine (1) · Boston Medical Center (1) · Center Eugene Marquis (1) · Industrial Microbiology LLP (1) · Jean-Pierre Routy (1) · Johns Hopkins University (1) · Massachusetts General Hospital (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Universidade Federal Fluminense (1) · Universitaire Ziekenhuizen KU Leuven (1) · University Hospital of North Norway (1) · University of Oxford (1) · Vanderbilt University Medical Center (1)
United States (4) · Malawi (2) · Bangladesh (1) · Belgium (1) · Brazil (1) · Canada (1) · France (1) · Kazakhstan (1) · Kenya (1) · Norway (1) · Uganda (1)
Benjamin Shayo, MD (1) · Carolina Berini, Dr. (1) · Douglas Kwon, MD, PhD (1) · Gerry Mullin, MD (1) · Ilyas Kulmagambetov, Doctor of Med. Sc. (1) · James A Berkley, MD (1) · Jeroen Raes, PhD (1) · Severine Vermeire, MD & PhD (1) · Tamar Barlam, MD MSC (1)
PMID 22265264, PMID 24891990, PMID 28390459, PMID 28605006, PMID 29100842, PMID 29615661, PMID 30480772, PMID 31270648, PMID 32173258, PMID 32385871, PMID 32433595, PMID 32600259, PMID 32633595, PMID 34677696, PMID 35562576, PMID 35601423, PMID 35998741, PMID 36239787, PMID 36733569, PMID 41390455, PMID 42643234
D43TW012274 (1)